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Abstract
While the profiling of subtypes of Attention Deficit Hyperactivity Disorder (AD/HD) have been the subject of considerable
scrutiny, both psychometrically and psychophysiologically, little attention has been paid to the effect of diagnoses
comorbid with AD/HD on such profiles. This is despite the greater than 80% prevalence of comorbidity under the DSM-IV-TR
diagnostic definitions. Here we investigate the event related potential (ERP) and psychometric profiles of Controls, AD/HD,
and comorbid AD/HD (particularly AD/HD+ODD/CD) groups on six neurocognitive tasks thought to probe the constructs of
selective and sustained attention, response inhibition and executive function. Data from 29 parameters extracted from a
child group (age range 6 to 12; 52 Controls and 64 AD/HD) and from an adolescent group (age range 13 to 17; 79 Controls
and 88 AD/HD) were reduced via a Principal Components Analysis, the 6 significant eigenvectors then used as determinants
of cluster membership via a Two-Step Cluster Analysis. Two clusters were found in the analysis of the adolescent age group
- a cluster dominated by Control and AD/HD participants without comorbidity, while the second cluster was dominated by
AD/HD participants with externalising comorbidity (largely oppositional defiant/conduct disorder ODD/CD). A similar
segregation within the child age group was not found. Further analysis of these objectively determined clusters in terms of
their clinical diagnoses indicates a significant effect of ODD/CD comorbidity on a concurrent AD/HD diagnosis. We conclude
that comorbid externalising behaviour in AD/HD constitutes a distinct pathological entity in adolescence.
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Introduction
Although the Diagnostic and Statistical Manual of Mental
Disorders, DSM-IV-TR [1] views Attention-Deficit/Hyperactivity
Disorder (AD/HD) as a homogenous disorder, this view has been
strongly contested. Previous research has repeatedly shown AD/HD
to be heterogeneous in its presentation, genetics, severity, comor-
bidity, and treatment outcome [2,3,4,5]. In a Swedish study [6] with
children meeting the full criteria for AD/HD, 87% of their sample
had at least one comorbid diagnosis and 67% had two or more
comorbid diagnoses (of which oppositional defiant disorder and
developmental coordination disorder were the most common). The
multidimensional nature of the disorder is also suggested by the
numerous theoretical models of aetiology and the variable global
prevalence rates. Viewing AD/HD as a homogenous disorder may
well account for negative or ambiguous findings in previous research,
and it is for this reason that some authors have begun to investigate
the existence of AD/HD subtypes or groups that are independent
from those defined by the DSM-IV-TR, particularly in terms of
comorbidity. In this regard, the World Health Organisation’s
International Classification of Diseases (ICD), which is used
predominantly in Europe, defines comorbid combinations of
disorders. Of particular interest is the ICD diagnosis of Hyperkinetic
Conduct Disorder (HCD), which is the diagnostic equivalent to the
combination of DSM-IV-TR’s AD/HD and Oppositional Defiant
Disorder (ODD) and/or Conduct Disorder (CD). Hence, the ICD
considers AD/HD+ODD/CD to represent a distinct pathological
entity, rather than a simple ‘‘combining of symptoms’’. This view has
gained some support in the previous AD/HD literature arguing for
either the delineation of a distinct subtype of AD/HD comorbid with
ODD/CD [7], or that AD/HD+ODD/CD should constitute a
separate pathological entity altogether [8], similar to that adopted by
the ICD.
The argument against a new subtype of AD/HD incorporating
ODD/CD comorbidity has stemmed from research findings
suggesting that AD/HD+ODD/CD represents a ‘‘hybrid’’ group
where the symptomatology is additive [9,10] and does not venture
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outside the realms of each disorder and hence does not constitute a
distinct pathological entity. This finding was supported by a study
by Rommelse et al [11] who found that while AD/HD+ODD/
CD was a more severe form of AD/HD, it did not produce deficits
in executive function (EF) and related motor components beyond
the independent effects of AD/HD, and ODD/CD. In sharp
contrast to this, Banaschewski et al [8] conducted a study utilising
a cued Continuous Performance Task (CPT-AX) which found that
the ‘hybrid’ concept was not able to account for the symptom-
atology of AD/HD+ODD/CD, and hence argued for the re-
conceptualisation of AD/HD+ODD/CD as a distinct pathological
entity. Though this debate has remained unresolved, it has fuelled
research investigating the possible existence of AD/HD diagnostic
groups that deviate from the DSM-IV-TR nomenclature.
Quantitative electroencephalography (QEEG) can play a
pivotal role in documenting cerebral dysfunction in attention
disordered individuals, and initial research has shown such results
with AD/HD populations. A study by Chabot and Serfontein [12]
found two distinct electrophysiological subtypes within their AD/
HD population, both indicative of abnormal central nervous
system arousal. Similarities in QEEG values were found between
the AD/HD subtypes Inattentive (AD/HD-I) and Combined
(AD/HD-C), suggesting comparability of underlying aetiology,
and consequently providing a new perspective for subtype
categorisation. Their study however, did not account for overt
comorbidity such as Oppositional Defiant Disorder/Conduct
Disorder (ODD/CD) within their AD/HD population. This
may explain why later research by Clarke, Barry, McCarthy and
Selikowitz [13] found conflicting results in terms of the type of
QEEG similarities and differences in their AD/HD group. Clarke
et al conducted a within-subtype analysis with children diagnosed
as AD/HD-C (combined subtype) with no internalised (i.e.
depression, anxiety, etc) or externalised (i.e. ODD/CD) comor-
bidity. Within this population, the authors isolated three distinct
QEEG-defined subtypes associated with cortical hypoarousal,
maturational lag, and cortical hyperarousal. An adjunct study
focusing on AD/HD-I instead found very similar results with two
QEEG profiles indicative of cortical hypoarousal, and matura-
tional lag [14]. Event-related potentials (ERPs) from an Oddball
task in the same AD/HD-I cohort showed only the early ERP
negativity N1 to significantly differ between the QEEG-defined
AD/HD-I subtypes - all other ERPs were comparable [15]. Two
possible explanations ensue. It may be that the generation of
cortical ERPs is primarily unaffected by underlying brain
abnormalities, or secondly, both cortical hypoarousal and matu-
rational lag are characterized by largely the same type of brain
abnormalities or produce similar task-processing deficits. Since
previous research has shown the EEG waveform to fluctuate and
change in accordance with physical and mental activity [16,17], it
is reasonable to assume that any underlying EEG abnormality
would be reflected in the task-related ERPs.
These studies suggest the existence of distinct AD/HD subtype
groups that are independent of the behaviourally-defined DSM-
IV-TR diagnostic criteria. To date, no investigation has been
conducted into the ERP and psychometric profiles that may exist
between/within Controls, AD/HD, and AD/HD+ODD/CD that
lie outside the DSM-IV-TR diagnostic guidelines. This is of
particular interest given the continuing debate regarding the
classification of AD/HD+ODD/CD as a distinct pathological
entity, in addition to the highly publicised symptom heterogeneity
in AD/HD groups with and without comorbidity [3,18] that can
often result in behavioural and/or cognitive overlap between these
groups. Therefore, the aim of this study is to ascertain whether
ERP and psychometric performance profiles of AD/HD with and
without ODD/CD comorbidity cluster into meaningful groups
that suggest a divergence in the nomenclature of the DSM-IV-TR.
A data-driven approach was adopted utilising six tasks probing the
core deficits in AD/HD, including selective attention, sustained
attention, hyperactivity and impulsivity, and executive function.
These functions were examined both psychometrically and
psychophysiologically (using event-related brain evoked poten-
tials). Data-driven research has gained considerable support over
the past decade as it can often generate unexpected findings that
would not have been anticipated by hypothesis-driven research
alone.
Methods
Participants
Electrophysiological and psychometric performance data was
recorded from 152 AD/HD male participants and 131 healthy
age-matched male Controls, within a study approved by the
Swinburne Human Research Ethics Committee, with participants
giving written informed consent (according with the Declaration of
Helsinki). Although data from female AD/HD participants was
obtained, the numbers between comorbid groups were insufficient
to allow a reliable analysis by gender. Hence, only the data from
the male participants are included in this study. Groups were
subdivided into children aged 6–12 years, and adolescents aged
13–17 years (see Table 1).
A one-way ANOVA showed no significant difference in age
between AD/HD and Controls for either children
[F(1,160),0.01, p= .998], or adolescents [F(1,178),0.01,
p= .983], and no significant difference in educational level
between AD/HD and Controls [children: F(1,160) = .050,
p= .824; adolescents: F(1,178) = .746, p= .389]. Group size, age
and level of education are shown below in Table 1.
All three subtypes of AD/HD (Inattentive: AD/HD-I, Com-
bined: AD/HD-C, and Hyperactive/Impulsive: AD/HD-HI)
were represented in the AD/HD population, although equal
proportions could not be maintained. However, since the current
investigation is not assessing subtype differences, an unequal
representation of each subtype was not considered a significant
limitation. A breakdown of AD/HD subtype numbers in each age
group is provided in Table 1.
Participants were excluded if English was not their primary
language, if they had a personal history of a physical brain injury,
stroke, or other neurological disorder, or any serious medical
condition related to the thyroid or heart or a history of cancer,
unconsciousness resulting from a blow to the head within the last
five years, a blood-borne illness, a severe impediment in vision
(that could not be corrected, for example with glasses) such as
colour vision, hearing or hand movement, a history of drug
addiction, a history of heavy alcohol consumption, or a personal or
familial genetic disorder. Participants (both AD/HD and Control)
were also excluded if their IQ was below 80, as measured by the
full-scale (WISC III) IQ or the Kaufman Brief Intelligence Test
(K-BIT2) [19]. The Spot the Real Word test [20] was utilised to
provide an ‘IQ estimate’ where WISC III or K-BIT2 information
was unavailable. This test has shown a high correlation (r=0.76)
with the full-scale WAIS III IQ [21].
All AD/HD participants were referred by their respective
clinician in the community, who confirmed AD/HD as the
primary diagnosis prior to admission into the study. After referral,
each AD/HD diagnosis was verified via the Diagnostic Interview
for Children and Adolescents (DICA), completed by the parent or
guardian at the time of testing. All AD/HD participants were
either medication naı̈ve at the time of testing, or had undergone a
Comorbidity in AD/HD
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minimum 48-hour washout period prior to testing (20% of
participants underwent a minimum 48-hour washout from
methylphenidate, 8.24% from dexamphetamine, and 71.76%
were medication naı̈ve). AD/HD participants were excluded if any
psychiatric disorder other than AD/HD was present (for example
Tic Disorder, Autism Spectrum Disorder, etc). Where comorbidity
was present, AD/HD was required as the primary diagnosis for
inclusion in this study.
Exclusion criteria specific to Controls consisted of any personal
or family history of AD/HD, or any other psychiatric disorder. To
screen for any undiagnosed common psychiatric disorders within
this cohort, the Somatic and Psychological Health Report 12
(SPHERE-12) [23,24] was administered. All Controls identified as
‘‘SPHERE-12’’ cases were excluded.
Multi-site data collection was carried out from Australian
laboratories located in Melbourne, Adelaide, and Sydney. Testing
and practice protocols were identical between laboratories,
conforming to the standards of the Brain Resource International
Brain Database (BRID, Brain Resource Company), to ensure
comparability of the data collected. Consistency between sites has
been demonstrated [25,26,27], along with the reliability and
validity of each psychophysiological and psychometric task
contained within the BRID standard testing battery [26,27,28].
AD/HD Comorbidity Profile
Details regarding comorbidity for each AD/HD participant was
provided by their respective clinician and further corroborated by
the DICA, completed by a parent or guardian at the time of
testing. Comorbidities among the AD/HD population consisted of
ODD/CD, Learning Disorder (LD), Anxiety (ANX), and Depres-
sion (DEP). Comorbidity in the child and adolescent AD/HD
participants is shown below in Table 2.
Where more than one comorbid disorder was present (12.63%
of the AD/HD sample), grouping was based according to the
presence or absence of ODD/CD. If ODD/CD was present as
well as LD for example, the participant was grouped into the
ODD/CD category. ‘AD/HD-NK’ will be used to denote AD/
HD participants whose assessment of comorbidity by their
paediatrician was negative at the time of interview, that is ‘no
known’ comorbidity. This assessment was later confirmed at the
time of testing via the DICA. Importantly, no participant in this
group was diagnosed with ODD/CD. ‘AD/HD+INT’ will be used
to denote AD/HD participants with internalising (Learning
Disorder, Anxiety, Depression, etc) comorbidity.
A one-way ANOVA with Bonferroni post-hoc comparisons
confirmed that there were no significant differences in age between
these child [F(3, 158) = .123, p= .947], or adolescent groups [F(3,
176) = .746, p= .526].
Severity of behavioural pathology in the AD/HD cohort was
measured via the Conners’ Parent Rating Scale – Revised Long
form (CPRS-R:L) [22], with all subscales included: oppositional,
cognitive problems/inattention, hyperactivity, anxious-shy, per-
fectionism, social problems, psychosomatic, AD/HD index,
restless-impulsive, emotional lability, global index total, DSM-IV
inattentive, DSM-IV hyperactive-impulsive, and DSM-IV symp-
toms total. Scores on each of these subscales were converted to T-
scores prior to analysis via a one-way ANOVA with Bonferroni
post-hoc comparisons. In children, AD/HD+INT scored higher
on the anxious-shy subscale and emotional lability than AD/HD-
NK (p= .003, p= .013 respectively), AD/HD+ODD/CD scored
higher on social problems than either AD/HD+INT (p= .01) or
AD/HD-NK (p= .005), AD/HD+INT scored higher than either
AD/HD+ODD/CD or AD/HD-NK on inattentive score (p,.001
for both comparisons). In adolescents, AD/HD+ODD/CD scored
higher on the oppositional subscale than either AD/HD-NK
(p= .048) or AD/HD+INT (p= .005). AD/HD+ODD/CD also
scored higher on hyperactivity than AD/HD+INT (p= .042) or
AD/HD-NK (p= .036). AD/HD+ODD/CD scored higher than
AD/HD+INT on the restless-impulsive subscale (p= .011), emo-
tional lability (p= .009), and on the global index total (p= .003).
Table 1. Average age and years of education for AD/HD and Control groups.
AD/HD Subtype* Subtype n Total N Mean Age (yr) (SD)
Years of Education Mean
(SD)
Children AD/HD I 18 64 9.08 (1.52) 3.71 (1.60)
C 42
HI 4
Controls 52 9.08 (1.52) 3.77 (1.59)
Adolescents AD/HD I 38 88 14.12 (1.43) 8.66 (1.53)
C 48
HI 2
Controls 79 14.13 (1.43) 8.86 (1.58)
*AD/HD subtypes: I = Inattentive, C = Combined, HI = Hyperactive/Impulsive.
doi:10.1371/journal.pone.0041407.t001
Table 2. Comorbidity profile (number and percentage of sample) of the AD/HD children and adolescents.
Externalising (ODD/CD) Internalising* (LD/ANX/DEP) None/Not known
Children 32 (50%) 11 (17%) 21 (33%)
Adolescents 35 (40%) 17 (19%) 36 (41%)
*Includes three AD/HD participants with (1) social problems and high IQ, (2) fine motor delay, and (3) retardation; ‘LD’ = Learning Disorder, ‘ANX’ = Anxiety, ‘DEP’ = Depression.
doi:10.1371/journal.pone.0041407.t002
Comorbidity in AD/HD
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On the latter subscale, AD/HD+ODD/CD also scored higher
than AD/HD-NK (p= .019).
Tasks and Procedure
All participants were seated in front of a computer screen in a
light and sound attenuated room. Data from six psychophysio-
logical and psychometric tasks were utilised in this investigation.
These are listed below along with their respective domains of
measurement shown in parenthesis.
i. Auditory Oddball Task (selective attention)
ii. Continuous Performance ‘‘one-back’’ Task (sustained atten-
tion)
iii. Go/NoGo Task (response inhibition: RI)
iv. Verbal Interference Task (RI)
v. Executive Maze Task (executive function: EF)
vi. Switching Of Attention Task (EF)
Auditory Oddball Task
Participants were presented with high ‘target’ tones (1000 Hz) and
low ‘standard’ tones (500 Hz) binaurally via headphones at 75 dB.
The duration of each tone was 50 ms (including 5 ms rise/fall times),
with an ISI of 1 s. All participants were instructed to respond via
button-press to target tones only, with speed and accuracy equally
stressed prior to task commencement. A short practice session was
conducted to ensure task instructions had been understood.
A total of 340 tones were presented, (280 standard tones; 60
target tones). Tones were presented within a single block in a
quasi-random order with no two target tones presented consec-
utively. Task duration was six minutes. ERPs were identified
within the following component windows: N1 (70–120 ms), P2
(120–220 ms), N2 (120–300 ms), and P3 (220–550 ms). Indicators
of behavioural performance consisted of Reaction Time (RT),
Standard Reaction Time (SDRT), False Positives (FPs), and False
Negatives (FNs).
Continuous Performance Task (CPT)
The CPT utilised in this study consisted of a series of letters (B,
C, D and G) which were presented one at a time on an otherwise
blank computer screen. The duration of each letter was 200 ms,
with an inter-stimulus interval (ISI) of 2.5 s. All participants were
instructed to respond via button-press when the same letter
appeared twice in a row, with speed and accuracy equally stressed
prior to task commencement. A short practice session was allowed
to ensure task instructions had been understood.
A total of 125 stimuli was presented: 85 background/non-target
letters; 20 pseudo-randomly presented target letters (repetitions of
the previous letter); and 20 distracter stimuli. The distracter
stimulus consisted of a black and white checkerboard (with each
black/white square being approximately 161 cm), which was
randomly interleaved with the letter stimuli. All participants were
instructed to ignore the checkerboards. Task duration was eight
minutes. Indicators of psychometric performance on this task
consisted of reaction time (RT) and its standard deviation (SDRT),
false positive errors (FPs) and false negative errors (FNs).
Go/NoGo Task (GNG)
The stimuli for the GNG task consisted of the word ‘‘PRESS’’
which was written in either green or red. A green PRESS was
classified as the ‘Go’ stimulus, while the red PRESS was classified
as the ‘No-Go’ stimulus. Each stimulus was presented on a
computer screen for 500 ms, with an ISI of 1 s.
The word PRESS was presented on the computer screen in a
pseudo-random order, a total of 28 times. A green (Go) PRESS
was shown 21 of those times, while a red (No-Go) PRESS was
shown 7 times. The green (Go) PRESS stimulus appeared 6 times
consecutively at the beginning of the task so as to increase the
perceived stimulus probability. This was followed immediately by
a red (No-Go) PRESS stimulus. The remainder of the tasks
consisted of random presentations of the Go and No-Go stimuli.
Task duration was five minutes.
ERP component windows varied slightly in this task compared
to the auditory Oddball task, and are defined as follows: N1 (95–
170 ms), P2 (200–280 ms), N2 (220–350 ms), and P3 (300–
450 ms). Indicators of psychometric performance consisted of
RT, SDRT, FPs, and FNs.
Verbal Interference Task (VIT)
The Verbal Interference Task (VIT) is a variant of the Stroop
Colour-Word Test [29] which assesses the asymmetric pattern of
interference control between colour-naming and word-reading
[30]. The VIT differs qualitatively from the Stroop test only in the
method of response; while the Stroop test requires a verbal
response, the VIT employed a computerised (touch-screen)
response system. The VIT utilised here comprises two components
of progressive difficulty.
Colour words were presented on the touch-screen one at a time.
In the first component, the participant was only required to
identify the colour word by pressing the matching response word
at the bottom of the touch-screen. In the second component,
rather than identifying the colour word, the participant was
required to identify the colour that the word was printed in, by
pressing the matching response word. Both speed and accuracy
were equally stressed in the task instructions and a short practise
session was allowed to ensure these instructions had been
understood. In both components, colour words would remain on
the screen until the participant responded. The duration of each
component was one minute.
Indicators of psychometric performance consisted of the
number of correctly identified colour words from component
one, and typeface colour from component two.
Executive Maze Task (EM)
The Executive Maze task is a variant of the Austin Maze which
primarily assesses visuo-spatial ability, memory, and learning, and
also provides secondary insight into planning, error utilisation, and
working memory abilities [31].
The Executive Maze task was presented on a computer screen
as a grid (868 matrix) of circles. The objective of this task is to find
and remember a hidden path through the grid. Participants were
required to use a directional button box in order to navigate their
way through the grid and find the hidden path through trial and
error. Correct moves were denoted by a green tick at the bottom
of the screen and accompanied by a tone, whereas incorrect moves
were denoted by a red cross at the bottom of the screen and
accompanied by a, lower-pitched tone. When the participant was
able to complete the maze without error twice consecutively, the
task concluded. Each participant was given no longer than seven
minutes to reach this goal, after which this task was discontinued.
Indicators of psychometric performance consisted of the total
number of errors made, and the total time taken to complete the
task.
Switching Of Attention Task (SOAT)
The Switching of Attention Task (SOAT) is a variant of the
Trail Making Test [32] and assesses general attentional function-
Comorbidity in AD/HD
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ing and executive function (planning, and switching of attention),
visuomotor tracking, and motor speed. The SOAT comprises two
components or ‘trails’ of differing difficulty levels; the first trail
measures the basic ability to maintain attentional focus on a simple
task, while the more challenging second trail measures the ability
to alternate attention between two simple mental sets.
In the first trail, participants are presented with 25 numbered
circles in ascending order (that is, 1 – 2 – 3, etc). These circles are
scattered in a fixed pseudo-random order on the touch-screen and
the participant is required to identify each circle in ascending
numerical sequence by touching the appropriate circle on the
touch screen. The second trail involves the identification of both
numbers and letters in ascending but alternating order (that is, 1 –
A – 2 – B – 3 – C, etc). The numbers 1–13 and the letters A–L are
presented in circles, again in a fixed pseudo-random order on the
touch-screen. Indicators of psychometric performance consisted of
the time taken to complete each trail. Electrophysiological data
was not collected during this task.
EEG Acquisition
Data was acquired from 32 channels including 26 scalp sites:
Fp1, Fp2, F7, F3, Fz, F4, F8, FC3, FCz, FC4, T3, C3, Cz, C4, T4,
CP3, CPz, CP4, T5, P3, Pz, P4, T6, O1, Oz, and O2 (NuAmps,
Neuroscan, Melbourne, Australia; 10–20 International System).
Impedance was below 5 kV at the beginning of testing. Data were
recorded relative to the virtual ground and re-referenced offline to
linked mastoids. Horizontal eye-movements were recorded with
electrodes placed 1.5 cm lateral to the outer canthus of each eye.
Vertical eye movements were recorded with electrodes placed
3 mm above the middle of the left eyebrow and 1.5 cm below the
middle of the left bottom eye-lid. A continuous acquisition system
was employed and data was EOG-corrected offline [33]. The
sampling rate was 500 Hz. Individual single-trial epochs were
filtered with a low-pass Tukey (cosine taper to 35 Hz) filter. The
single trials were then averaged to form conventional ERPs to
deviants, from which N1, N2, P2 and P3 amplitudes and latencies
were derived according to the component windows specified
above.
Spatial averaging of EEG data. In order to maximise the
amount of meaningful data included in the analysis, ERPs were
averaged across multiple scalp sites according to topographic
location and areas of maximal activation (see Table 3), as is typical
of studies that incorporate a large amount of ERP data [34,35,36].
This was done regardless of cognitive paradigm.
Analysis
A total of 29 variables were selected for inclusion in a Principal
components analysis (PCA) (see Table 4). Reaction times (RT)
were established for oddball and CPT tasks, and ERP data was
selected from Oddball and Go-NoGo tasks.
Statistical Analysis
Prior to statistical analysis, square root transformations were
performed on all error scores (FPs, and FNs) due to their skewed
distributions. Analysis of data in this study was two-fold. Firstly,
psychometric performance, and amplitude and latency ERP
variables from the six tasks were incorporated into a Principal
Components Analysis (PCA) in order to reduce the amount of
data. Secondly, a Two-Step Cluster Analysis using the PCA-
derived factors was conducted using a log-likelihood distance
measure and the Schwarz’s Bayesian Clustering Criterion (BIC).
The Cluster Analysis was run for both children and adolescents,
with no number of clusters specified a priori. Bonferroni corrections
were applied.
Since variables with larger values can have a stronger impact on
clustering than those with smaller values [37], all of the PCA-
derived factors were automatically standardised as z-scores (x=0,
SD=1) prior to analysis, as part of the two-step Cluster process.
Significant differences between clusters in each age group were
determined via Mann-Whitney U Tests due to skewed distribu-
tions in the PCA-derived factors. Permutation testing on group
centroid distances in Z-space of the most significant predictors was
also carried out.
Results
Principal Components Analysis
The factorability of these 29 variables used (Table 4) was
supported by both the Kaiser-Meyer-Oklin value (.811) which
exceeded the recommended threshold of .60 [38], and by a
significant Bartlett’s Test of Sphericity (p,.001) [39]. Nine
components were found with eigenvalues (proportional to the
total variance explained by that eigenvector) greater than one.
Since components in the PCA were standardised to a variance of
1, only eigenvalues .1 were retained. However, following a
Parallel Analysis [40] with 100 randomly generated replications of
the same dataset matrix, only six Principal components were
finally retained (Parallel Analysis was conducted using the Monte
Carlo PCA for Parallel Analysis computer software [41]).
An exploratory factor analysis was then carried out. Given that
each PCA component is considered to represent a different facet of
attention and cognition, an oblique rotational method was
employed. The six Principal components were rotated using a
Promax rotation. The pattern matrix from this rotation is shown in
Table 5.
Each of the six components identified via the PCA comprised of
a range of variables originating from different tasks, which renders
a sensible naming difficult. Thus, for each component, the
variables that had the highest loadings will be taken as the best
representative of any underlying construct(s) [42]. According to
Hair, Anderson, Tatham and Black [43], a loading of 0.6 or above
is considered as ‘‘high’’, and a loading of 0.7 indicates that roughly
half of the variance in that factor is accounted for by that variable.
The largest number of task variables were grouped together to
form Factor 1. Of these variables, three had loadings at or above
0.6 these were the ERP components P3 and N2 latency from the
GNG task, along with P3 latency from the Oddball task. The N2
ERP component has previously been found to be a reliable marker
of the inhibitory process [44,45,46], in addition to stimulus
discrimination or the ‘mismatch detection’ process [47,48]. Given
this, it appears that Factor 1 is representative of complex
processing related to task difficulty. Since this Factor is largely
comprised of ERP component latency and RT variables, higher
scores would be indicative of greater impairment.
Table 3. Spatial averaging of ERPs.
Topographic Location Scalp Sites Averaged
Fronto-Central N1 Fp1, Fp2, F7, F3, Fz, F4, F8, FC3, FCz, FC4
Fronto-Central N2 Fp1, Fp2, F7, F3, Fz, F4, F8, FC3, FCz, FC4
Central P2 T3, C3, Cz, C4, T4, CP3, CPz, CP4
Centro-Parietal P3 CP3, CPz, CP4, T5, P3, Pz, P4, T6
doi:10.1371/journal.pone.0041407.t003
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Factor 2 was wholly comprised of variables from the Executive
Maze task with 3 variables possessing factor loadings .0.7
(Preservative Errors, Non-Preservative Errors, and Time per
Trial), suggestive of deficits in visuo-spatial abilities as previously
identified in AD/HD [43,49] and AD/HD+ODD/CD [50]
cohorts.
The variables that comprised Factor 3 were error-related, with
only two (Total FPs and FNs from the Oddball task) having a
factor loading at or higher than 0.6 (though with FPs from the
GNG task giving a factor loading = .599). Together they could be
described as relating to error monitoring.
Factor 4 was wholly comprised of ERP components derived
from the auditory Oddball task; four in total with three being
latency ERPs. Out of these four variables, two possessed factor
loadings above 0.7 (P2L and N1L), and one had a factor loading
above .6 (N2L). Previously, these ERPs have been reported as
reflective of the initial orienting of attention (N1) [47,48,51,52],
and the automatic inhibition of irrelevant stimuli (P2, N2)
[44,46,47,48,53]. Note that in a fashion similar to Factor 1,
higher scores in Factors 2, 3, and 4 reflect greater impairment.
Factor 5 showed major contributions from four variables,
mostly derived from the visual GNG task. Of the four variables,
two had factor loadings $0.6 (P2A and N2A), with one of out the
two having a factor loading above ..7 (P2A). Given that the ERP
components P2 and N2 have been suggested to reflect facets of the
inhibitory process, this Factor may therefore be interpreted as
corresponding to response inhibition [54,55].
Factor 6 possessed only one variable with a factor loading ..6,
though another variable did approach this threshold (N2A: factor
loading = .582). As both ERP components here were derived from
the auditory Oddball task, this factor may be representative of an
auditory selective attention process.
Cluster Analysis
The six rotated Factors obtained via the PCA were then
subjected to a Cluster Analysis to investigate the possible presence
of AD/HD groups that differ from those defined in the DSM-IV-
TR.
Adolescent group
In the adolescent analysis, two clusters were identified with 113
participants in the first cluster (Cluster 1), and 54 participants in
the second cluster (Cluster 2). Between the two adolescent clusters,
Cluster 2 appears to be more of a ‘Clinical’ group due to the
comparatively greater populations of AD/HD+ODD/CD and
AD/HD+INT (internalising) than in Cluster 1 which is predom-
inately comprised of Controls (see Table 6 and Figure 1).
Of the six factors, Factors 2, 3, and 5 all significantly (with
Bonferroni corrections) contributed to defining Clusters 1 and 2.
Factors 2 and 3 contributed significantly more to Cluster 2 than
Cluster 1, and Factor 1 was more prominent in Cluster 2
Table 4. Final 29 variables included in the Principal components analysis.
Variable Task Underlying Construct
Psychometric:
Incongruent Trial Score VIT RI
Incongruent Error Score VIT RI
Trail Completion Difference* SOAT EF
Maze Trial Time* EM visual information processing/task performance
Perseverative Errors EM visual information processing/task performance
Non-Perseverative Errors EM visual information processing/task performance
Path Learning Time* EM visual information processing/task performance
RT Oddball selective attention
FNs Oddball selective attention
FPs GNG RI
RT CPT sustained attention
FNs CPT sustained attention
Total FPs CPT/Oddball hyperactivity/impulsivity
Electrophysiological#:
N1A, N1L Oddball orienting of attention
P2A, P2L Oddball automatic inhibition
N2A, N2L Oddball inhibitory/mismatch process
P3A, P3L Oddball complex information processing
N1A, N1L GNG orienting of attention
P2A, P2L GNG automatic inhibition
N2A, N2L GNG inhibitory/mismatch process
P3A, P3L GNG complex information processing
*‘Trail Completion Difference’ was measured as the difference in completion times between the two trails of the SOAT; ‘Maze Trial Time’ is the time taken to complete the trial
twice consecutively without error; ‘Path Learning Time’ is the time taken to learn the path prior to completing the trial twice consecutively without error (i.e. the time taken
from the start of the first trial till the end of the last trial with one or more errors).
#The letter ‘A’ or ‘L’ is added to the end of each ERP component to denote amplitude (A) or latency (L), for example ‘N1A’ denotes fronto-central N1 amplitude.
doi:10.1371/journal.pone.0041407.t004
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compared to Cluster 1 (see Figure 2). As discussed earlier, Factor 1
is thought to represent complex processing related to task
difficulty, and Factors 2 and 3 are thought to be indicative of
task performance deficits, with Factor 2 being more specific to
visuo-spatial processing. Therefore, it appears that Cluster 2
displayed more task performance deficits, and impaired complex
processing related to task difficulty, compared to Cluster 1.
Of particular interest was the greater number of AD/HD-NK
adolescents in Cluster 1 than Cluster 2. To see whether this cluster
distribution was an effect of AD/HD subtype, a Chi-Square Test
was conducted post-hoc (with AD/HD-HI excluded from this
analysis since there were only two adolescents in total). The
difference in AD/HD subtype distributions between Clusters 1
and 2 did not reach significance (x2 = 2.096, p= .148). Therefore,
the characteristics of each adolescent Cluster is independent of
AD/HD subtype. A second Chi-Square test was conducted to
verify that comorbidity significantly differed between the two
adolescent Clusters; this was confirmed: x2 = 46.587, p,.001. A
one-way ANOVA was also conducted to confirm that cluster
distribution was not an effect of intelligence; no significant
difference in IQ estimates was found between Clusters 1 and 2
[F(1, 166) = .372, p= .543].
Importantly, the Z-score data from the three most predicative
factors for cluster membership (Eigenvectors 2, 3 and 5) were
subjected to a permutation testing routine to test the hypothesis
that comorbid diagnosis of AD/HD+ODD/CD would show an
objective separation from the group comprising AD/HD without
a diagnosis of ODD/CD (a comparison of AD/HD with
Externalising comorbidity with other AD/HD participants (with
Internalising or no comorbidity)). Visualization of the data via a
3D scatter plot shows a clear separation of the two groups (see
Figure 3, and the movie in Supplementary Movie S1).
The Pythagorean distance between centroids of the two groups
of points was then calculated. A permutation test was constructed
using LabVIEW (National Instruments, Austin USA) based on the
null hypothesis that all of the points derive from one population
and were thus randomly selected into two groups, of the same sizes
as the experimental groups, 10000 times, and each time the
Pythagorean distance between centroids in Z-space was calculated.
The experimental datum (1.0856) ranked 4th highest, resulting in
an equivalent (two-tailed) probability of p,.001. Testing of the
other combinations of clinical AD/HD comorbid diagnoses did
not result in significant separation.
Table 5. Promax rotated pattern matrix - six eigenvector solution from PCA.
EigenV 1 EigenV 2 EigenV 3 EigenV 4 EigenV 5 EigenV 6
P3L (GNG) .739
N2L (GNG) .721
P3L (Oddball) .652
N1A (GNG) 2.593
EF(SOAT) .539
P2L (GNG) .528
RT (Oddball) .493
Incong. Trial Score 2.451
N1L (GNG) .449 .324
RT (CPT) .409
Persev. Errors .923
Non-Persev. Errors .896
Time per Trial .728
Path Learning Time .349 .524
Total FPs .788
FNs (Oddball) .661
FPs (GNG) .599
FNs (CPT) .566
Incong. Error Score .531
P2L (Oddball) .873
N1L (Oddball) .784
N2L (Oddball) .366 .655
N1A (Oddball) 2.582 .404
P2A (GNG) .551 .767
N2A (GNG) .628
P3A (GNG) 2.327 .525
P3A (Oddball) .487 .307
P2A (Oddball) .815
N2A (Oddball) 2.484 .384 .582
doi:10.1371/journal.pone.0041407.t005
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Child group
Only one cluster was found in the child analysis which
comprised all 116 Clinical and Control children. The scores on
each of the six factors from the PCA analysis did not display any
pattern that could segregate the children into more than one
cluster. It appears that that the variance in the six factors was too
great to result in a significant difference between children from the
Clinical and Control groups. This view is borne out by
visualization of the 3-factor plot (factors 2, 3 5) for children with
AD/HD+ODD/CD and those with AD/HD without known
comorbidity (see Figure 4, and the movie in Supplementary Movie
S2).
Discussion
The aim of this study was to investigate whether the child and
adolescent Clinical and Control populations could be clustered
into meaningful groups divergent from that defined by the DSM-
IV-TR. This clustering was based on the six factors from a
Principal Components Analysis of 29 data variables derived from a
battery of six neurocognitive tasks. The relative impact of ODD/
CD comorbidity in AD/HD was also investigated. The results
showed a single collective cluster in the child group, and two
clusters in the adolescent group which were suggestive of ‘clinical’,
and ‘normal/sub-clinical’ populations.
No significant factors were found in the child analysis. In
adolescence, three factors (2, 3, and 5) dictated cluster membership
more so than any of the other factors. Both Factors 2 and 3 are
thought to be indicative of task performance, with Factor 2 being
more specific to visuo-spatial processing. Factor 5 was thought to
reflect response inhibition specific to visual information processing.
Factor 1 was also found to significantly discriminate Cluster 2 from
Cluster 1, though not vice versa. Factors 2 and 3, which are both
thought to be related to task performance, were found to be the
two most prominent factors in this analysis. This is unsurprising
given that previous research has found task performance to be
significantly more impaired in AD/HD populations, particularly
when inhibitory tasks are involved [46,56,57,58,59,60,61]. There-
fore, it was also unsurprising to find that Cluster 2, which had the
larger Clinical population, displayed substantially more impair-
ment as indexed by these two factors than Cluster 1. This finding
is strengthened by the fact that greater impairment in complex
processing relating to task difficulty was a defining characteristic of
Cluster 2, rather than Cluster 1. The significant differences in
Factor 5 were also strongly indicative of comparatively more
impairment in Cluster 2 than Cluster 1.
In the child analysis, only one cluster was found which included
all 116 Clinical and Control children. Although AD/HD is
typically first diagnosed in childhood, this is also the time when
behaviour and development (both physical and cognitive) is the
most fluid; any model of ‘‘misbehaviour’’ may be difficult to apply
to young cohorts as it may only be representative of a transient
phase in development. As a result, any variable dependent on such
Table 6. The two clusters produced from the adolescent
cluster analysis, and the percentage distribution of Clinical
and Control participants in each cluster.
Cluster 1 N Cluster % Cluster 2 N Cluster %
Controls 71 63.7% Controls 7 13.0%
AD/HD+ODD/CD 11 9.7% AD/HD+ODD/CD 24 44.4%
AD/HD+INT 7 6.2% AD/HD+INT 10 18.5%
AD/HD2NK 23 20.4% AD/HD2NK 13 24.1%
Comorbidities ODD/CD: Oppositional Defiant Disorder/Conduct Disorder; INT:
internalising comorbidities; NK: no known comorbidity.
doi:10.1371/journal.pone.0041407.t006
Figure 1. Variable-wise importance charts. Chi-square values for
each of the six factors are shown with significant factors (those that
exceeded the Critical Value indicated by the dashed lines) highlighted
for (a) Cluster 1, and (b) Cluster 2, in descending order.
doi:10.1371/journal.pone.0041407.g001
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factors is likely to be applicable only to a more discrete point in
time in the child’s development. This highlights the massive scope
for variability, which was evident in each of the six factors. Of the
116 Clinical and Control children, none of the data on the six
factors showed any form of homogeneity that would allow cluster
formation due to the substantial amount of variability. Therefore,
this result supports the widely held contention in AD/HD research
that the overwhelming symptom heterogeneity which is consis-
tently found in AD/HD populations appears to be at its most
pronounced in childhood. Given this, a more individualistic
approach to diagnosis of disruptive behaviour disorders, such as
AD/HD, in childhood is encouraged, as such heterogeneity can
impede effective treatment regimes if a generalised approach is
adopted at this age.
Comorbid subgroups in childhood AD/HD did not cluster into
meaningful groups divergent from the core disorder of AD/HD or
from Controls, suggesting that overt and covert comorbidity can
manifest as highly variable symptomatology that is not dissimilar
between groups. Previous research has shown comorbidity such as
ODD/CD to be more prevalent in older AD/HD cohorts [62],
therefore, AD/HD children diagnosed with comorbid ODD/CD
may be more representative of a prodromal comorbid group that
are less symptomatic and less impaired than their older counter-
parts. This result therefore challenges the reliability of comorbid
ODD/CD diagnoses in AD/HD children aged 6–12 years, and
highlights the need for age-appropriate diagnostic criteria.
Figure 4. 3D scatter plot of Child AD/HD+ODD/CD (red dots)
and AD/HD without comorbid diagnosis (blue dots) plotted on
axes of the same factors (2,3 and 5) predictive of clustering in
the adolescent analysis, scaled as Z-scores (Z-Error Monitoring,
Z-Inhibitory processing, Z-Visuospatial learning, respectively).
doi:10.1371/journal.pone.0041407.g004
Figure 2. Mean Factor loadings and standard errors of the
adolescent Clusters 1 and 2 (Total C1, Total C2) for each of the
six factors (F1–F6). In addition the mean Factor scores for each of the
Comorbidity subcategories are plotted (Control: Cont; AD/HD+ODD/CD:
ODD; Internalising: INT; AD/HD-NK: NK).
doi:10.1371/journal.pone.0041407.g002
Figure 3. 3D scatter plot of Adolescent AD/HD+ODD/CD (red
dots) and AD/HD without comorbid diagnosis (blue dots)
plotted on axes of the most significant factors (2,3 and 5) from
the PCA analysis, scaled as Z-scores (Z-Error Monitoring, Z-
Inhibitory processing, Z-Visuospatial learning, respectively).
doi:10.1371/journal.pone.0041407.g003
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The adolescent analysis produced quite different results to that
of the children. Two clusters were found; Cluster 1 which
resembled a more ‘normal’ or ‘sub-clinical’ group, and Cluster 2
which clearly represented a more ‘clinical’ group. This interpre-
tation was primarily fuelled by the population distributions of the
Controls, AD/HD+INT, and AD/HD+ODD/CD. Almost two
thirds of the entire Cluster 1 population were Controls, while
almost half of Cluster 2 was AD/HD+ODD/CD. There were also
slightly more AD/HD+INT adolescents in Cluster 2 than there
were in Cluster 1. Given this, it appears that ODD/CD
comorbidity in AD/HD is a primary factor in distinguishing
behavioural and/or attentional dysfunction against Controls and
hence may bias the diagnosis of AD/HD in adolescents. In the
absence of such comorbidity, AD/HD-NK displayed a more
varied result with 64% of the total population grouped into Cluster
1 with the bulk of the Controls, and 36% grouped into the more
‘clinical’ Cluster 2. Firstly, this suggests some overlap in
neurocognitive performance, or some confusion of behavioural
diagnosis. Such an overlap can be interpreted as representing
dimensional impairment if members of the AD/HD-NK group in
Cluster 2 do in fact possess sub-clinical levels of ODD/CD
symptomatology. Future research is needed to clarify the
dimensional nature of symptomatology and symptom severity
between AD/HD comorbid groups. Secondly, the AD/HD-NK in
Cluster 1 may represent the gradual dissipation of overt symptoms
with age [63,64,65,66] and hence, the general decrease in
dysfunction and symptom severity. Both of these explanations
may be concurrently valid.
The present results in terms of AD/HD-NK can be seen as
reminiscent of previous QEEG findings which have typically
shown two groups within the AD/HD subtypes that are
independent from the DSM-IV-TR definition [13,14,67]. With
the two cluster-defined AD/HD-NK groups, Cluster 2 clearly
displayed more impairment than Cluster 1, which was not found
to be an effect of AD/HD subtype. In the previous research also,
two groups (cortical hypoarousal and maturational lag) were
found, though analyses did not reveal any significant differences to
indicate a more impaired group [15]. The concepts of matura-
tional lag and cortical hypoarousal have repeatedly been applied
to AD/HD populations in the previous literature [68,69,70,71],
with positive results suggesting both theories are equally valid,
however some authors argue that AD/HD subjects display deviant
maturation, rather than maturational lag per se [72]. Cortical
hypoarousal in particular has recently been linked to inhibition
[69]. It is also possible that the two theories are linked, rather than
occurring in parallel, that is, one might act as a catalyst for the
other. It is difficult to declare that the two AD/HD-NK groups
found here displayed signs of maturational lag or cortical
hypoarousal as the present results did not incorporate an analysis
of quantitative EEG or imaging data. However, an early study
linked developmental immaturity to persistent and extreme
overactivity [73], suggesting that clinical levels of hyperactivity
and impulsivity were indicative of a maturational lag. Given this
finding, it can be reasoned that the more impaired AD/HD-NK in
cluster 2 may have displayed a maturational lag compared to the
less impaired AD/HD-NK cohort in cluster 1. This contention is
based on the type of Factors that were most successful in
identifying task-defined symptom severity, and subsequent cluster
membership; Factors 2, 3 and 5 represent components of
attention, learning, and inhibition, all of which are strongly
influenced by hyperactivity and impulsivity.
Hyperactive and impulsive symptoms have consistently been
linked to ODD/CD comorbidity, and greater overall symptom
severity in AD/HD samples [74,75,76,77,78,79,80]; a study by
Decker et al. [81] for example, found comorbid CD is more likely
to be diagnosed in AD/HD subtypes with hyperactive/impulsive
symptoms than inattentive symptoms. Given this, the primary
distinguishing characteristic between the adolescent clusters 1 and
2 is likely to be task-defined hyperactivity and/or impulsivity, as
captured by Factors 2, 3 and 5, which appear to be most
pronounced in AD/HD+ODD/CD adolescents.
Task performance as dictated by these three factors also
illustrated a clear distinction between AD/HD-NK and AD/
HD+ODD/CD adolescents, suggesting a significant divergence in
task-defined symptom severity. Previous research on comorbid
AD/HD has repeatedly shown AD/HD+ODD/CD to display
significantly greater symptom severity compared to AD/HD-alone
[62,77,82]. This result supports previous claims that AD/
HD+ODD/CD may constitute a distinct pathological entity [8]
rather than a ‘hybrid’ group. A hybrid group would be expected to
display a noticeable overlap in task performance scores with AD/
HD+ODD/CD, suggesting a dimensional increase in symptom
severity, however this did not appear to be the case here. Rather, it
appears that task-defined symptom severity in AD/HD+ODD/
CD adolescents is beyond that defined under the AD/HD-NK
umbrella.
From the results found here, the most intriguing was the lack of
any Clinical/Control cluster formations in the child analysis. In
sharp contrast to the adolescent results, the six factors did not show
any distinguishable pattern between any of the Clinical or Control
groups and as a result, all of the children were clustered together.
This finding could partly be accounted for by the inherent
heterogeneity in AD/HD, however similar variability appeared to
be present in the Control children also. This suggests that
symptomatology and symptom severity in AD/HD exists on a
dimensional scale that stems from ‘normal’ cognitive and
behavioural function as seen in the Controls, rather than an
arbitrary counting of symptoms deemed to be abnormal or
maladaptive as per the DSM-IV-TR definition. Given that both
physical and cognitive development is at its most fluid state in
childhood, the single cluster result found for this age group is
contextually unsurprising.
Overall, the adolescent clusters differed primarily in terms of
task-related hyperactivity and/or impulsivity as defined by error
rate (Factors 2 and 3) and visual response inhibition (Factor 5).
The results obtained with these Factors suggest that measures of
hyperactivity/impulsivity and visual response inhibition may serve
as diagnostic aids in a clinical setting, or as profiling anchors in
future research. These factors indexed greater impairment,
particularly when ODD/CD comorbidity was present in AD/
HD. Given this finding, the present results support the idea that
AD/HD+ODD/CD can be distinguished on a dimensional scale
from AD/HD-NK in adolescence. Hence, it may prove beneficial
for comorbidity such as ODD/CD to be incorporated into the
diagnostic definition of AD/HD and consequently into the
diagnostic process, particularly when AD/HD progresses from
childhood into adolescence. Such a stance has already been
adopted in the ICD, where a distinct diagnosis of Hyperkinetic
Conduct Disorder (HCD) is made for AD/HD+ODD/CD [83].
The question then arises as to whether or not AD/HD+ODD/CD
should be defined as a distinct pathological entity in the
forthcoming DSM-V. Although the affirmative has been argued
by Banaschewski et al [8], others have argued that AD/
HD+ODD/CD is more of a ‘hybrid’ group characterised by a
greater severity of the same symptomatic domains [9,10], a
contention supported by Rommelse et al [11] who described
AD/HD+ODD/CD symptomatology as ‘‘more of the same’’
(p. 802) rather than a phenotypically distinct subtype. The results
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from this study indicate that ODD/CD comorbidity has a
significant impact on the neurocognitive performance of adoles-
cents diagnosed with AD/HD and hence supports a revision of the
current AD/HD nomenclature to allow AD/HD+OD/CD to be
seen as a distinct pathological entity, however this appears to be
valid only in adolescence; there does not appear to be a similar
pattern of results supportive of such nomenclature in childhood.
Rather, childhood diagnosis would benefit from a dimensional
approach to symptomatology and symptom severity.
Supporting Information
Movie S1 Movie showing an orbital view of the 3D
scatter plot of Adolescent AD/HD+ODD/CD (red dots)
and AD/HD without comorbid diagnosis (blue dots)
plotted on the Z-Error Monitoring, Z-Inhibitory pro-
cessing and Z-Visuospatial learning axes. A clear separa-
tion of the red and blue dots is seen.
(MOV)
Movie S2 Movie showing an orbital view of the 3D
scatter plot of Child AD/HD+ODD/CD (red dots) and
AD/HD without comorbid diagnosis (blue dots) plotted
on the Z-Error Monitoring, Z-Inhibitory processing and
Z-Visuospatial learning axes. No clear separation is seen
between the child comorbid groups.
(MOV)
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